These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 36074098)

  • 1. A Meta-Analysis of Antipsychotic-Induced Hypo- and Hyperprolactinemia in Children and Adolescents.
    Krøigaard SM; Clemmensen L; Tarp S; Pagsberg AK
    J Child Adolesc Psychopharmacol; 2022 Sep; 32(7):374-389. PubMed ID: 36074098
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipsychotic-Related Prolactin Levels and Sexual Dysfunction in Mentally Ill Youth: A 3-Month Cohort Study.
    Koch MT; Carlson HE; Kazimi MM; Correll CU
    J Am Acad Child Adolesc Psychiatry; 2023 Sep; 62(9):1021-1050. PubMed ID: 36931560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quetiapine versus other atypical antipsychotics for schizophrenia.
    Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
    Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative physiological effects of antipsychotic drugs in children and young people: a network meta-analysis.
    Rogdaki M; McCutcheon RA; D'Ambrosio E; Mancini V; Watson CJ; Fanshawe JB; Carr R; Telesia L; Martini MG; Philip A; Gilbert BJ; Salazar-de-Pablo G; Kyriakopoulos M; Siskind D; Correll CU; Cipriani A; Efthimiou O; Howes OD; Pillinger T
    Lancet Child Adolesc Health; 2024 Jul; 8(7):510-521. PubMed ID: 38897716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    De Hert M; Yu W; Detraux J; Sweers K; van Winkel R; Correll CU
    CNS Drugs; 2012 Sep; 26(9):733-59. PubMed ID: 22900950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic Treatment Effectiveness in First Episode of Psychosis: PAFIP 3-Year Follow-Up Randomized Clinical Trials Comparing Haloperidol, Olanzapine, Risperidone, Aripiprazole, Quetiapine, and Ziprasidone.
    Gómez-Revuelta M; Pelayo-Terán JM; Juncal-Ruiz M; Vázquez-Bourgon J; Suárez-Pinilla P; Romero-Jiménez R; Setién Suero E; Ayesa-Arriola R; Crespo-Facorro B
    Int J Neuropsychopharmacol; 2020 Apr; 23(4):217-229. PubMed ID: 31974576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoprolactinemia and hyperprolactinemia in male schizophrenia patients treated with aripiprazole and risperidone and their relationships with testosterone levels.
    Tasaki M; Yasui-Furukori N; Yokoyama S; Shinozaki M; Sugawara N; Shimoda K
    Neuropsychopharmacol Rep; 2021 Sep; 41(3):379-384. PubMed ID: 34189861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization risk in patients with schizophrenia treated with dose-equivalent antipsychotics.
    Ng-Mak D; Messali A; Huang A; Wang L; Loebel A
    Am J Manag Care; 2019 Jul; 25(14 Suppl):S279-S286. PubMed ID: 31365818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Add-on effects of a low-dose aripiprazole in resolving hyperprolactinemia induced by risperidone or paliperidone.
    Qiao Y; Yang F; Li C; Guo Q; Wen H; Zhu S; Ouyang Q; Shen W; Sheng J
    Psychiatry Res; 2016 Mar; 237():83-9. PubMed ID: 26921057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis.
    Almandil NB; Liu Y; Murray ML; Besag FM; Aitchison KJ; Wong IC
    Paediatr Drugs; 2013 Apr; 15(2):139-50. PubMed ID: 23519708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
    Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
    Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
    Kishi T; Ikuta T; Matsuda Y; Sakuma K; Okuya M; Nomura I; Hatano M; Iwata N
    Mol Psychiatry; 2022 Feb; 27(2):1136-1144. PubMed ID: 34642461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive aripiprazole in the treatment of risperidone-induced hyperprolactinemia: A randomized, double-blind, placebo-controlled, dose-response study.
    Chen JX; Su YA; Bian QT; Wei LH; Zhang RZ; Liu YH; Correll C; Soares JC; Yang FD; Wang SL; Zhang XY
    Psychoneuroendocrinology; 2015 Aug; 58():130-40. PubMed ID: 25981348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life among patients treated with lurasidone: results from a switch trial in patients with schizophrenia.
    Awad G; Hassan M; Loebel A; Hsu J; Pikalov A; Rajagopalan K
    BMC Psychiatry; 2014 Feb; 14():53. PubMed ID: 24559217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Umbrella Review: Association Between Antipsychotic Drugs and Metabolic Syndrome Hallmarks in Children and Adolescents.
    Carnovale C; Battini V; Santoro C; Riccio MP; Carucci S; Nobile M; Formisano P; Bravaccio C; Zuddas A; Clementi E; Pozzi M; Pisano S
    J Am Acad Child Adolesc Psychiatry; 2024 Mar; 63(3):313-335. PubMed ID: 37391174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-Response Meta-Analysis of Antipsychotic Drugs for Acute Schizophrenia.
    Leucht S; Crippa A; Siafis S; Patel MX; Orsini N; Davis JM
    Am J Psychiatry; 2020 Apr; 177(4):342-353. PubMed ID: 31838873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study.
    Park YM; Lee SH; Lee BH; Lee KY; Lee KS; Kang SG; Lee HY; Kim W
    Psychiatry Res; 2016 May; 239():184-9. PubMed ID: 27010188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole.
    Lu ML; Shen WW; Chen CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and network meta-analysis on comparative efficacy, acceptability, and safety of treatments in acute bipolar mania in youths.
    Tural Hesapcioglu S; Kasak M; Abursu H; Kafali S; Ceylan MF; Akyol M
    J Affect Disord; 2024 Mar; 349():438-451. PubMed ID: 38211745
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.